These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3496055)

  • 21. Modulation of cartilage destruction by select nonsteroidal antiinflammatory drugs. In vitro effect on the synthesis and activity of catabolism-inducing cytokines produced by osteoarthritic and rheumatoid synovial tissue.
    Herman JH; Appel AM; Hess EV
    Arthritis Rheum; 1987 Mar; 30(3):257-65. PubMed ID: 3494454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intercellular messengers in joint tissues in rheumatoid arthritis. How disturbed control mechanisms may contribute to tissue destruction and repair.
    Russell RG; McGuire MK; Meats JE; Ebsworth NM; Beresford J
    Scand J Rheumatol Suppl; 1981; 40():75-87. PubMed ID: 6100920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial purification of a factor from human synovium that possesses interleukin 1, chondrocyte stimulating and catabolin-like activities.
    Elford PR; Meats JE; Sharrard RM; Russell RG
    FEBS Lett; 1985 Jan; 179(2):247-51. PubMed ID: 3917934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunorecognition of chondrocytes in articular cartilage activated by synovial interleukin 1.
    Davies ME; Horner A; Dingle JT
    Connect Tissue Res; 1991; 25(3-4):243-9. PubMed ID: 1711948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of cartilage breakdown by hydrocortisone in a tissue culture model of rheumatoid arthritis.
    Steinberg JJ; Kincaid SB; Sledge CB
    Ann Rheum Dis; 1983 Jun; 42(3):323-30. PubMed ID: 6859964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synovial factors and chondrocyte-mediated breakdown of cartilage: inhibition by hydrocortisone.
    Steinberg JJ; Sledge CB
    J Orthop Res; 1983; 1(1):13-21. PubMed ID: 6679571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on mechanisms of cartilage destruction in rheumatoid arthritis.
    Sheppeard H
    Aust N Z J Med; 1983 Apr; 13(2):195-200. PubMed ID: 6311151
    [No Abstract]   [Full Text] [Related]  

  • 28. Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha.
    Gravallese EM; Pettit AR; Lee R; Madore R; Manning C; Tsay A; Gaspar J; Goldring MB; Goldring SR; Oettgen P
    Ann Rheum Dis; 2003 Feb; 62(2):100-7. PubMed ID: 12525377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I.
    Sugiyama E; Taki H; Kuroda A; Mino T; Yamashita N; Kobayashi M
    Ann Rheum Dis; 1996 Jun; 55(6):375-82. PubMed ID: 8694577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response.
    Furuzawa-Carballeda J; Macip-Rodríguez PM; Cabral AR
    Clin Exp Rheumatol; 2008; 26(4):554-60. PubMed ID: 18799084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
    Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
    Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis.
    Jüngel A; Distler JH; Kurowska-Stolarska M; Seemayer CA; Seibl R; Forster A; Michel BA; Gay RE; Emmrich F; Gay S; Distler O
    Arthritis Rheum; 2004 May; 50(5):1468-76. PubMed ID: 15146416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of prostaglandins from rheumatoid synovium in inhibition of articular cartilage metabolism.
    Lippiello L; Yamamoto K; Robinson D; Mankin HJ
    Arthritis Rheum; 1978; 21(8):909-17. PubMed ID: 737014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.
    Chabaud M; Durand JM; Buchs N; Fossiez F; Page G; Frappart L; Miossec P
    Arthritis Rheum; 1999 May; 42(5):963-70. PubMed ID: 10323452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts.
    Dodge GR; Hawkins D; Boesler E; Sakai L; Jimenez SA
    Osteoarthritis Cartilage; 1998 Nov; 6(6):435-40. PubMed ID: 10343777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium.
    Firestein GS; Berger AE; Tracey DE; Chosay JG; Chapman DL; Paine MM; Yu C; Zvaifler NJ
    J Immunol; 1992 Aug; 149(3):1054-62. PubMed ID: 1386092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of laminin and of the laminin receptor integrin subunit alpha 6 in situ correlates with cytokine induced down regulation of alpha 6 on fibroblast-like synoviocytes from rheumatoid arthritis.
    Rinaldi N; Barth TF; Weis D; Schwarz-Eywill M; Pezzutto A; Lukoschek M; Brocai D; Brado B
    Ann Rheum Dis; 1998 Sep; 57(9):559-65. PubMed ID: 9849316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
    Cawston TE; Curry VA; Summers CA; Clark IM; Riley GP; Life PF; Spaull JR; Goldring MB; Koshy PJ; Rowan AD; Shingleton WD
    Arthritis Rheum; 1998 Oct; 41(10):1760-71. PubMed ID: 9778217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
    Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
    Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synovial cartilage interactions with special reference to the prostanoids as metabolic agents in cartilage under normal and pathological conditions.
    Mitrovic D
    Eur J Rheumatol Inflamm; 1982; 5(1):3-14. PubMed ID: 7044794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.